← Back to Trial

DESTINY-PANTUMOUR04

Trial Locations

• Research Site Birmingham, Alabama, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Bullhead City, Arizona, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Casa Grande, Arizona, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site San Diego, California, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Boulder, Colorado, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Coral Springs, Florida, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site St. Petersburg, Florida, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site West Palm Beach, Florida, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Decatur, Illinois, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Topeka, Kansas, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Farmington, New Mexico, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Durham, North Carolina, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Wilson, North Carolina, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Canton, Ohio, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Maumee, Ohio, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Philadelphia, Pennsylvania, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Nashville, Tennessee, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Dallas, Texas, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)